These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 31577674

  • 1. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
    Brahmbhatt M, Prenner S, Bittermann T.
    Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
    [Abstract] [Full Text] [Related]

  • 2. Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Lai Q, Feys E, Karam V, Adam R, Klempnauer J, Oliverius M, Mazzaferro V, Pascher A, Remiszewski P, Isoniemi H, Pirenne J, Foss A, Ericzon BG, Markovic S, Lerut JP, European Liver Intestine Transplant Association (ELITA).
    Transplantation; 2017 Mar; 101(3):555-564. PubMed ID: 28212256
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience.
    Nudo CG, Yoshida EM, Bain VG, Marleau D, Wong P, Marotta PJ, Renner E, Watt KD, Deschênes M.
    Can J Gastroenterol; 2008 Oct; 22(10):821-4. PubMed ID: 18925305
    [Abstract] [Full Text] [Related]

  • 4. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
    Nagai S, Kitajima T, Yeddula S, Salgia R, Schilke R, Abouljoud MS, Moonka D.
    Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
    [Abstract] [Full Text] [Related]

  • 5. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
    Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, Boleslawski E, Burroughs A, Sellés CF, Jaeck D, Pfitzmann R, Salizzoni M, Söderdahl G, Steininger R, Wettergren A, Mazzaferro V, Le Treut YP, Karam V, European Liver Transplant Registry.
    Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
    [Abstract] [Full Text] [Related]

  • 6. Hepatic Epithelioid Hemangioendothelioma: A Rare Disease With Favorable Outcomes After Liver Transplantation.
    Krasnodębski M, Grąt M, Morawski M, Wierzchowski M, Jastrzębski M, Remiszewski P, Zając K, Patkowski W, Zieniewicz K.
    Transplant Proc; 2020 Oct; 52(8):2447-2449. PubMed ID: 32217012
    [Abstract] [Full Text] [Related]

  • 7. Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation.
    Remiszewski P, Szczerba E, Kalinowski P, Gierej B, Dudek K, Grodzicki M, Kotulski M, Paluszkiewicz R, Patkowski W, Zieniewicz K, Krawczyk M.
    World J Gastroenterol; 2014 Aug 28; 20(32):11333-9. PubMed ID: 25170219
    [Abstract] [Full Text] [Related]

  • 8. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N, Reichman TW, Amiri Y, Carmody IC, Galliano G, Seal J, Bugeaud E, Bohorquez H, Bruce D, Cohen A, Loss GE.
    Liver Transpl; 2017 Mar 28; 23(3):299-304. PubMed ID: 28026108
    [Abstract] [Full Text] [Related]

  • 9. Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy.
    Ishaque T, Beckett J, Gentry S, Garonzik-Wang J, Karhadkar S, Lonze BE, Halazun KJ, Segev D, Massie AB.
    Transplantation; 2024 Aug 01; 108(8):e170-e180. PubMed ID: 38548691
    [Abstract] [Full Text] [Related]

  • 10. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
    Mehta N, Dodge JL, Roberts JP, Yao FY.
    J Hepatol; 2021 Apr 01; 74(4):829-837. PubMed ID: 33188904
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG.
    Hepatology; 2020 Dec 01; 72(6):2014-2028. PubMed ID: 32124453
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of the Liver Transplant Waiting List in Our Center.
    Emek E, Yesim Kara Z, Demircan FH, Serin A, Yazici P, Sahin T, Tokat Y, Bozkurt B.
    Transplant Proc; 2019 Sep 01; 51(7):2413-2415. PubMed ID: 31474297
    [Abstract] [Full Text] [Related]

  • 18. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D, French B, Abt P, Feng S, Cameron AM.
    Liver Transpl; 2012 Apr 01; 18(4):434-43. PubMed ID: 22271656
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.